Molecule Structure

Scientific Name

Eribulin

Description of the Drug

Eribulin is a microtubule inhibitor used to treat metastatic breast cancer and metastatic or unresectable liposarcoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB08871

Brand Name(s)

Halaven

Company Owner(s)

Eisai Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL15783821
DrugBank DB08871
PubChem: Thomson Pharma 16446284
PubChem 11354606
PDBe 6K9
DrugCentral 4171
ChemicalBook CB22546700
Guide to Pharmacology 6813
GSRS 5b1fac26-2fd7-4d53-a73f-8b05a3553ba0
rxnorm ERIBULIN MESYLATE HALAVEN ERIBULIN
ChEBI 63587
ZINC ZINC000169344691